Yuan et al. demonstrated that mice with an endothelial specific deletion in Wnt5a have persistent PAH and importantly, treatment of pulmonary microvascular endothelial cells obtained from PAH patients with Wnt5a enriched exosomes enhanced the migration/repair effects in wound-healing assays (Yuan et al., 2019). Here, WNT5A is linked to pulmonary arterial hypertension.